^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CD40 ligand expressing MSLN-CAR T

    i
    Other names: CD40 ligand expressing MSLN-CAR T
    Associations

    News

    Trials
    Company:
    UTC Therap
    Drug class:
    Mesothelin-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    CD40 Ligand Expressing MSLN-CAR T Cell Therapy in MSLN Positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
    P1/2, N=30, Recruiting, Chinese PLA General Hospital
    New P1/2 trial • CAR T-Cell Therapy • Metastases
    |
    MSLN (Mesothelin) • CD40LG (CD40 ligand)
    |
    MSLN expression
    |
    albumin-bound paclitaxel • cyclophosphamide • fludarabine IV • CD40 ligand expressing MSLN-CAR T